Skip to Main Content

Author Details

Christine L Clarke
Westmead Institute for Medical Research, University of Sydney
1978
145
51
PMIDPaper TitleJournal TitlePublished Year
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
35933885Incorporating progesterone receptor expression into the PREDICT breast prognostic model.Eur J Cancer2022
36328784Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.Br J Sports Med2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
35933885Incorporating progesterone receptor expression into the PREDICT breast prognostic model.Eur J Cancer2022
36328784Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.Br J Sports Med2022
32359158Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.J Natl Cancer Inst2021
32359158Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.J Natl Cancer Inst2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34146516Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.Am J Hum Genet2021
33826649Increased prevalence of obstructive sleep apnea in women diagnosed with endometrial or breast cancer.PLoS One2021
33500318Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2021
34341517Mendelian randomisation study of smoking exposure in relation to breast cancer risk.Br J Cancer2021
34407845Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Breast Cancer Res2021
33826649Increased prevalence of obstructive sleep apnea in women diagnosed with endometrial or breast cancer.PLoS One2021
33500318Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2021
34407845Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Breast Cancer Res2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
34146516Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.Am J Hum Genet2021
34341517Mendelian randomisation study of smoking exposure in relation to breast cancer risk.Br J Cancer2021
33022221Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.Am J Hum Genet2020
31949161A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Nat Commun2020
33148314A tumour suppressive relationship between mineralocorticoid and retinoic acid receptors activates a transcriptional program consistent with a reverse Warburg effect in breast cancer.Breast Cancer Res2020
33022221Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.Am J Hum Genet2020
31949161A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Nat Commun2020
33148314A tumour suppressive relationship between mineralocorticoid and retinoic acid receptors activates a transcriptional program consistent with a reverse Warburg effect in breast cancer.Breast Cancer Res2020
30796232Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity.Sci Rep2019
30796232Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity.Sci Rep2019
31429584Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study.Biopreserv Biobank2019
31429584Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study.Biopreserv Biobank2019
28851667Estrogen and progesterone signalling in the normal breast and its implications for cancer development.Mol Cell Endocrinol2018
28851667Estrogen and progesterone signalling in the normal breast and its implications for cancer development.Mol Cell Endocrinol2018
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
30093612Identification of nine new susceptibility loci for endometrial cancer.Nat Commun2018
29214365Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.Clin Exp Metastasis2018
29915430A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet2018
30093612Identification of nine new susceptibility loci for endometrial cancer.Nat Commun2018
29214365Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.Clin Exp Metastasis2018
29058716Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet2017
29059683Association analysis identifies 65 new breast cancer risk loci.Nature2017
29058716Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet2017
28087820Emerging functional roles of nuclear receptors in breast cancer.J Mol Endocrinol2017
28087820Emerging functional roles of nuclear receptors in breast cancer.J Mol Endocrinol2017
29059683Association analysis identifies 65 new breast cancer risk loci.Nature2017
27083182Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.Breast Cancer Res Treat2016
27083182Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.Breast Cancer Res Treat2016
27211549The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis.EBioMedicine2016
27459855Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.Breast Cancer Res2016
  • 1 - 50 of 290

Recommended Authors

Dimple Chakravarty
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 0
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2004
Number of shared co-authors 9
Mona Shehata
University of Cambridge
Career Start Year 2004
Number of shared co-authors 5
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 2
Michael T Lewis
Baylor College of Medicine
Career Start Year 1996
Number of shared co-authors 4
Mercedes Jimenez-Linan
University of Cambridge
Career Start Year 1995
Number of shared co-authors 66
Martin Widschwendter
European Translational Oncology Prevention and Screening (EUTOPS) Institute
Career Start Year 1993
Number of shared co-authors 73
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 15
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 21
John P Lydon
Center for Coregulator Research, Baylor College of Medicine
Career Start Year 1991
Number of shared co-authors 7
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 11
Maria Lucia Hirata Katayama
School of Medicine of Sao Paulo University
Career Start Year 1991
Number of shared co-authors 0
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 4
Powel H Brown
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 10
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 37
Juha Kononen
Central Finland Hospital Nova
Career Start Year 1990
Number of shared co-authors 2
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 4
Cyril B Gilks
University of British Columbia
Career Start Year 1987
Number of shared co-authors 69
Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1987
Number of shared co-authors 0
Fred C G J Sweep
Radboud University Medical Centre
Career Start Year 1987
Number of shared co-authors 10
Alfredo A Molinolo
University of California
Career Start Year 1984
Number of shared co-authors 1
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 7
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 7
Christopher S Foster
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 20
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 9
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1
Erika Ginsburg
National Cancer Institute, National Institutes of Health
Career Start Year 1973
Number of shared co-authors 1
Veronica Clavijo Jordan
Harvard Medical School
Career Start Year 1971
Number of shared co-authors 6
Bert W O'Malley
Center for Coregulator Research, Baylor College of Medicine
Career Start Year 1964
Number of shared co-authors 0
Maria Mitzi Brentani
Sao Paulo University
Career Start Year 1964
Number of shared co-authors 0

Collaborators

J Dinny Graham
Westmead Institute for Medical Research
Co-authored papers 42
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Co-authored papers 34
Graham G Giles
Co-authored papers 26
Fergus J Couch
Mayo Clinic
Co-authored papers 25
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 24
Douglas F Easton
University of Cambridge
Co-authored papers 24
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 23
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 23
Per Hall
Co-authored papers 22
Alison M Dunning
Co-authored papers 22
Diether Lambrechts
Co-authored papers 22
Christopher A Haiman
University of Southern California
Co-authored papers 21
Hoda Anton-Culver
University of California irvine
Co-authored papers 21
Loic Le Marchand
Co-authored papers 20
Roger L Milne
Co-authored papers 20
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 20
Irene L Andrulis
University of Toronto
Co-authored papers 19
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 19
Esther M John
Co-authored papers 18
Jan Lubinski
Pomeranian Medical University
Co-authored papers 18
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 18
Janet E Olson
Mayo Clinic
Co-authored papers 17
Peter Kraft
Harvard T. H. Chan School of Public Health
Co-authored papers 17
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 17
Wei Zheng
Co-authored papers 15
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 14
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 14
Rudolf Kaaks
Co-authored papers 14
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 13
Xiao-Ou Shu
Co-authored papers 13
Release 1.2